614 related articles for article (PubMed ID: 19034878)
1. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
2. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
3. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
5. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
7. Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men.
Karaouzene N; Merzouk H; Aribi M; Merzouk SA; Berrouiguet AY; Tessier C; Narce M
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):792-9. PubMed ID: 20554180
[TBL] [Abstract][Full Text] [Related]
8. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
[TBL] [Abstract][Full Text] [Related]
9. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
10. Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.
Demirdag K; Yilmaz S; Ozdarendeli A; Ozden M; Kalkan A; Kilic SS
Hepatogastroenterology; 2003; 50(51):766-70. PubMed ID: 12828081
[TBL] [Abstract][Full Text] [Related]
11. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
12. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
13. [Role of free radical oxidation in the development of cardiovascular events in chronic renal failure].
Dzgoeva FU; Gatagonova TM; Dzugkoeva FS; Kochisova ZKh; Kadzaeva ZK; Khamitsaeva OV
Ter Arkh; 2010; 82(1):51-6. PubMed ID: 20364702
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
Baskol G; Atmaca H; Tanriverdi F; Baskol M; Kocer D; Bayram F
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):522-6. PubMed ID: 17853336
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in children with acute glomerulonephritis.
Bülbül M; Oner A; Demircin G; Erdoğan O
Ren Fail; 2008; 30(2):209-14. PubMed ID: 18300123
[TBL] [Abstract][Full Text] [Related]
16. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and antioxidant status in lichen planus.
Sezer E; Ozugurlu F; Ozyurt H; Sahin S; Etikan I
Clin Exp Dermatol; 2007 Jul; 32(4):430-4. PubMed ID: 17459065
[TBL] [Abstract][Full Text] [Related]
18. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis.
Uzun H; Yanardag H; Gelisgen R; Genc H; Uygun S; Vehid S; Karter Y; Demirci S
Curr Med Res Opin; 2008 Jun; 24(6):1651-7. PubMed ID: 18474147
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
